AtriCure Inc reports results for the quarter ended in September 30 - Earnings Summary

AtriCure

30/10/2024 03:08

* AtriCure Inc  ATRC.OQ  reported a quarterly adjusted loss
of 17
cents​​ per share for the quarter ended September 30, higher
than the same quarter last year, when the company reported EPS
of -20 cents.  The mean expectation of nine analysts for the
quarter was for a loss of 19 cents per share. Wall Street
expected results to range from -22 cents to -16 cents per share.
    * Revenue rose 17.9% to $115.91 million from a year ago;
analysts
expected $112.25 million. 
    * AtriCure Inc's reported EPS for the quarter was a loss
of 17
cents​.
    * The company reported a quarterly loss of $7.85 million.
    * AtriCure Inc shares had risen by 2.5% this quarter and
lost 19.4% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"

Wall Street's median 12-month price target for AtriCure Inc is
$38.00 
This summary was machine generated from LSEG data October 30 at
03:08 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.19          -0.17          Beat
 Jun. 30 2024      -0.17          -0.17          Met
 Mar. 31 2024      -0.23          -0.28          Missed
 Dec. 31 2023                     -0.21